Integrative genomic analysis of primary prostate tumors and associated LNM demonstrated the enrichment of mutations in several genes including both well-established oncogenes and tumor suppressors and understudied genes such as EYA1, CSMD3, FLT4, NCOR2, and PCDH15. This evidence concerns the gene FLT4 and prostate neoplasm.